The COVID-19 pandemic occurred in 2020.
CamerounCOVID-19observed 2020published 2022Journal of public health in Africaeurope_pmcdocument of 9 observationsDOI 10.4081/jphia.2022.2195
Gold tier: mechanically validated evidence, with its primary source.
1,754 evidence items · page 4 / 71
The COVID-19 pandemic occurred in 2020.
CamerounCOVID-19observed 2020published 2022Journal of public health in Africaeurope_pmcdocument of 9 observationsDOI 10.4081/jphia.2022.2195
75.1 %Prelingual deafness accounted for 75.1% of 582 patients with severe hearing loss in Cameroon.
Camerounprelingual deafnesspublished 2013European journal of medical geneticseurope_pmcdocument of 8 observations
40.1 %Le paludisme représente 40,1 % de la morbidité chez la population en général.
Camerounpaludismeobserved 2004HAL · Unilimdocument of 98 observations
4.3 %Serologic reactivity suggesting Simian immunodeficiency virus infection was found in 34 of 788 monkey sera, representing 4.3% with weak reactivity.
CamerounSimian immunodeficiency viruspublished 2002Emerging infectious diseasesOpenAlexdocument of 3 observationsDOI 10.3201/eid0805.010522
0.58 p_valueNo statistically significant difference was observed between the allelic frequencies of obese and non-obese subjects (p = 0.58).
Camerounobésitépublished 2017Journal of health, population, and nutritioneurope_pmcdocument of 3 observations
8.3 %Diabetes prevalence in 2021 was estimated to be 8.3% in rural areas.
Cameroundiabète (non précisé)observed 2021published 2022Diabetes research and clinical practiceeurope_pmcdocument of 7 observationsDOI 10.1016/j.diabres.2021.109119
6 %Anemia occurred in 6% of patients receiving stavudine-lamivudine-nevirapine.
Camerounanémiepublished 2008AIDS Research and Human RetrovirusesOpenAlexdocument of 10 observations
1.6 mmol/lTriglycerides decreased significantly from 1.6 mmol/l to 1.2 mmol/l in type 2 diabetes patients receiving ginger add-on therapy over six weeks.
Cameroundiabète de type 2published 2022Annales de cardiologie et d'angeiologieeurope_pmcdocument of 6 observations
2,336 per_100000Transport injuries had an age-standardised prevalence of 2336 cases per 100,000 in females in 2017.
Camerountransport injuriesobserved 2017published 2018Lancet (London, England)europe_pmcdocument of 14 observations
200 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol were less than 200 deaths per 100 000 for men in South Korea.
Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobserved 2010published 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument of 28 observationsDOI 10.1016/s2213-8587(14)70102-0
6.2 odds_ratioThere was an association between diabetes and peripheral neuropathy (OR 6.2 [95% CI: 3.4–11.2]).
Cameroundiabète (non précisé) · neuropathie périphériquepublished 2017BMC health services researcheurope_pmcdocument of 7 observationsDOI 10.1186/s12913-017-2197-0
13.5 %Among ART initiators with no prior exposure to antiretrovirals in urban areas of Cameroon, pretreatment HIV drug resistance (PDR) prevalence was 13.5% (95% CI 5.1%–31.5%).
CamerounVIH/sidaobserved 2015published 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 12 observationsDOI 10.1093/jac/dky221
18 %If post-2000 trends continue, by 2025 global obesity prevalence will reach 18% in men.
Camerounobésitéobserved 2025published 2016Lancet (London, England)europe_pmcdocument of 20 observations
32.1 %Twenty-seven of the 84 participants (32.1%) who did the first oral glucose tolerance test were diagnosed with gestational diabetes mellitus.
Cameroundiabète gestationnelpublished 2017BMC research noteseurope_pmcdocument of 2 observations
6 kgWeight increased by 6 kg between 3 and 12 months after camp.
Cameroundiabète de type 1observed 3 and 12 monthspublished 2016BMC endocrine disorderseurope_pmcdocument of 6 observations
75.2 %In Mfou, males had a multiclonal infection prevalence of 75.2% (240/319) compared to 62% (181/292) in females.
CamerounpaludismeHAL · Unilimdocument of 106 observations
13 %The global prevalence of the diabetic foot was found to be 13% among 300 diabetic patients.
Camerounpied diabétiquepublished 2005Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 10 observations
1 deathDuring the period of December 2004 to January 2005, Bacillus anthracis killed one gorilla (Gorilla gorilla gorilla) in a tropical forest in Cameroon.
Camerounanthraxobserved December 2004 to January 2005published 2006American Journal of PrimatologyOpenAlexDOI 10.1002/ajp.20298
8.2 %8.2% (4/49) of gorillas were reactive with WNV-NS1 in two different sites in Cameroon.
CamerounWest Nile viruspublished 2021PLoS neglected tropical diseasesOpenAlexdocument of 8 observationsDOI 10.1371/journal.pntd.0009028
68 per_1000_yearsMortality was 68.0 per 1000 years in children and adolescents with type 1 diabetes and no formal education in Cameroon between 2011 and 2015.
Cameroundiabète de type 1observed 2011-2015published 2022Pediatric diabeteseurope_pmcdocument of 5 observations
30 %Le ministère de la santé publique du Cameroun s'est engagé à ce que moins de 30 % des Camerounais souffrent des méfaits du paludisme en 2027.
Camerounpaludismeobserved 2027HAL · Unilimdocument of 98 observations
3.3 %The overall early vertical transmission rate of HIV among 1827 tested infants was 3.3% (95% CI 2.5–4.3).
CamerounVIH/sidaobserved November 2007 to October 2010published 2019Paediatrics and international child healthPubMeddocument of 7 observations
14.8 %Identified genetic causes accounted for 14.8% of 582 patients with severe hearing loss in Cameroon.
Camerounhearing losspublished 2013European journal of medical geneticseurope_pmcdocument of 8 observations
Early insulin secretion and maximal insulin secretion rate were lower in patients with ketosis-prone atypical diabetes compared with control participants.
Camerounketosis-prone atypical diabetespublished 2013Diabetes careeurope_pmcdocument of 3 observationsDOI 10.2337/dc12-0798
21 %If post-2000 trends continue, by 2025 global obesity prevalence will surpass 21% in women.
Camerounobésitéobserved 2025published 2016Lancet (London, England)europe_pmcdocument of 20 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.